Summary
52 / 100 · Bulios Score
What speaks for it
- The share price is below the Bulios Fair Price.
- Revenue grew by 12% a year over the last 3 years.
What to watch
- Out of every 100 RON of revenue, only 0.5 RON is left as net profit.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 19.1 RON for 1 RON of yearly profit.
Valuation in detailIs it growing?
Yes, fastRevenue (RON)
Diluted EPS (RON)
Revenue grew by 11% a year over 5 years. Over the last 3 years it grew by 12% a year. Earnings per share grew by 12% a year over the last 3 years.
Growth in detailDoes it make money?
PoorlyWhere 100 RON of revenue goes
- Cost of sales 92 RON
- Sales and administration 99 RON
- Taxes and other 0.6 RON
- Net profit 0.5 RON
Net profit, industry median (Medical - Distribution) 1.5 RON
Out of every 100 RON of revenue, 0.5 RON is left as net profit.
Profitability in detailIs it financially healthy?
No balance sheet is available.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
No coverageNo analyst covers this stock.
Analysts in detail